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The objective of this meta-analysis is to summarize the effect of exercise intervention on flow-mediated dilatation (FMD) in
overweight and obese adults. We searched four electronic databases (PubMed/Medline, Scopus, and CINAHL) through June 2016
for relevant studies pertaining to the effectiveness of exercise intervention on FMD. Seventeen of the 91 studies identified met the
inclusion criteria. Comprehensive Meta-Analysis software (version 3) was used to compute the standardized mean difference effect
size (ES) and 95% CI using a random effects model. We calculated 34 ESs. We found that exercise intervention had medium and
positive effects on FMD,with an overall ES of 0.522 (95%CI= 0.257, 0.786).Heterogeneity of ESswas observed (𝑄𝑏 = 239,𝑝 ≤ 0.001,
𝐼2 = 86.19), and the effect was moderated by comorbidity (𝑄𝑏 = 6.39, df = 1, 𝑝 = 0.011). A large ES for the combination exercise,
low intensity exercise, and comorbidity subgroups (ES = 0.82∼1.24) was found. We conclude that while exercise intervention
significantly improves FMD in overweight and obese adults, the effect may depend on the different characteristics of exercise
intervention and on participants’ demographics.
1. Introduction
Obesity, a chronic metabolic disorder, is strongly associated
with morbidity and mortality as well as a reduced life
expectancy [1]. Obesity is defined as an excessive accumu-
lation of adipose tissue. Globally, 1.9 billion adults are over-
weight or obese, and this figure has more than doubled in the
past two decades [2]. Epidemiological studies show that over-
weight and obese status in adults significantly increases the
risks of numerous cardiovascular and circulatory disorders,
for example, hypertension, stroke, coronary artery disease,
and heart failure [1, 3]. Some of the complex, interrelated
pathological states, for example, altered lipid profile and
elevated blood pressure, also associated with obesity, subse-
quently induce insulin resistance, vascular oxidative stress,
vascular endothelial dysfunction, and other debilitations [4–
6].
The vascular endothelium, which is a single layer of cells
lining the interior surface of blood vessels, plays a key role in
vasomotor regulationmainly through the nitric oxide- (NO-)
dependent signaling pathways [7]. The vascular endothelium
is a sensitive structure which is susceptible to damage by
certain lipids and inflammatorymediators [8]. Adipose tissue
is well known to be associated with inflammatory processes,
and it is also implicated in the production of reactive oxygen
species (ROS) [9]. Multiple studies provide evidence that
vascular endothelial function (EF) is impaired in the setting
of obesity [6, 10, 11]. Endothelial dysfunction is considered
to be an early precursor and common pathological feature of
vascular diseases [12].
Endothelial dysfunction is commonly evaluated by
flow-mediated dilatation (FMD) in human studies. The
FMD is a noninvasive clinical tool that measures shear
stress-mediated vasodilatory response and depends on NO
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bioavailability [7, 13]. One meta-analysis has reported an
association between a 1% decrease in FMD and an 8%
increase in the risk of future cardiovascular events [14].While
pharmacological intervention is often used to improve EF
or body weight (e.g., topiramate and metformin), regular
exercise training is a promising nonpharmacological option
in obesity treatment [15].
Although a recent meta-analysis demonstrated the ben-
eficial effect of exercise training on FMD in both obese
and nonobese adults [16], the included studies pool data
from both obese and nonobese groups, thus raising the
question of whether obesity status is a confounding factor
in accurate evaluation of FMD. Furthermore, the optimal
intensity, modality, and duration of exercise for improving
FMD are controversial [17–20].These and similar studies also
suggest there are several other potential factors confounding
measurement of FMD in the setting of obesity.
To address the inconclusive findings, we conducted
a meta-analysis to quantitatively evaluate the relationship
between exercise training and EF in overweight and obese
adults. We compared the effects of different characteristics
of exercise interventions and participants’ demographics on
FMD.
2. Methods
2.1. Literature Search. Source of data was identified by
keyword searched from four electronic databases: the
PubMed/Medline, Scopus, and CINAHL.The keywords used
to identify the relevant studies were “obesity”, “overweight”,
“exercise”, “training”, “flowmediated dilatation”, “flowmedi-
ated dilation”, and “FMD”. Additional potential sources were
identified by hand search using personal databases and a
reference list of published studies.
2.2. Inclusion and Exclusion Criteria. The studies were
included in the review if sufficient information was reported
that allowed us to compute the standardized mean difference
of FMD. Specific inclusion criteria for eligible studies were
the study (1) included the value of relative FMD; (2) included
exercise intervention at least 7 days; (3) considered only
overweight and/or obese adults; and (4) is written in English
language and published in peer-reviewed journals through
June 2016. Furthermore, studies were excluded if they were
purposefully designed for examining the effects of weight
loss medication, antiandrogens, fertility treatments, gluco-
corticoids, or oral contraceptives.
2.3. Coding and Data Extraction. The two authors (YS, SJ)
independently coded the identified studies using extraction
sheets. The characteristics of the studies were coded for
descriptive purposes and moderator analyses. Based on the
procedures recommended by Lipsey and Wilson (2005), the
outcome and moderator variables were extracted. The effect
size (ES) of outcome variable, FMD, was computed using (a)
before and after mean difference from intervention groups
divided by pooled standard deviation (SD) and (b) mean dif-
ference between intervention and control groups divided by
pooled SD. Also, moderator variables which may affect over-
all ES of FMDwere coded as follows: bodyweight change, diet
intervention, exercise duration/type/intensity, comorbidity,
and baseline Body Mass Index (BMI). Exercise intensity
and type were classified as low, moderate, and high intensity
using the definition of the American College of Sports
Medicine [21].
All coded data were crosschecked with authors for estab-
lishing consistency, and discrepancies were resolved by dis-
cussion. Figure 1 illustrates the schematic flow diagram of this
study describing the inclusion and exclusion procedures for
study selection [22].
2.4. Study Quality Rating. The methodological quality of
selected studies was assessed using the Physiotherapy Evi-
denceDatabase (PEDro) scale [40, 41].This scale consists of 11
items: random allocation, concealed allocation, similarity at
baseline, subject blinding, therapist blinding, assessor blind-
ing, >85% follow-up for at least one key outcome, intention-
to-treat analysis, between-group statistical comparison for at
least one key outcome, and point and variability measures for
at least one key outcome.The quality of studies is determined
based on the average of overall scores (range = 0–10; each
item, except for item 1, contributes one point) where higher
scores indicate better methodological quality. The average
total PEDro score is 5.0 ± 1.6 (mean ± SD) based on
27,444 records from the PEDro database on January 2017.
The scoring ≥ 6/10 was considered “moderate to high” for
methodological quality [42].
2.5. Data Analysis. All analyses were run in Comprehensive
Meta-Analysis version-3 software with a significance level
of 0.05. Because we assumed that the variety of research
designs with study characteristics might affect the true ES
from one study to another, a random effects model was
used to estimate the overall ES and 95% confidence intervals
(CIs). The measure of ES used for the present study is
the standardized mean difference, Cohen’s d. The ESs were
evaluated based on Cohen’s guideline, small (0.2), medium
(0.5), and large (0.8) [43]. The Cochran’s Q homogeneity
statistic was used to determine the heterogeneity of the mean
ESs across the groups. Moderator analyses were conducted
to test the ES difference among the categorical subgroups of
eachmoderator.Themean ES and 95CI of each subgroupwas
also examined to see if an exercise intervention has an effect
greater than zero. In addition, we examined the funnel plots,
the Duval and Tweedie’s trim and fill method, and Egger’s test
to detect the publication bias as all studies were published in
the peer-reviewed journals in which the results are possibly
subjected to publication bias.
3. Results
3.1. Search Results. Figure 1 outlines the flow diagram of the
study selection process. The literature search identified 91
articles.We next reviewed the articles in full text to determine
final eligibility. 17 studies ultimatelymet the eligibility criteria
providing sufficient information for computing ESs. Some of
the studies included results from separate, independent trials
testing the effects of two or more exercise modalities on EF,
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(n = 202)
Figure 1: Flowchart for selection of studies.
so the 17 studies yielded a total of 34 ESs for the final meta-
analysis.
3.2. Publication Bias. The funnel plot examination showed
that the publication bias had little influence on our result.
The studies included in the present meta-analysis were
symmetrically distributed around the mean ES. The Duval
and Tweedie’s trim and fill method also predicted no missing
study to this meta-analysis. However, the regression intercept
(3.37) from Egger’s test results was statistically significant
(𝑝 = 0.001) that a potential publication bias for this meta-
analysis should be noted for its interpretation.
3.3. Study Characteristics. The characteristics of these stud-
ies are shown in Table 1. Studies from around the world
were included, including North America, Australia, South
America, Europe, and Asia. They included women and men
(mean age = 47.23) who are overweight or obesity with or
without comorbidity. One trial used only men, 17 trials used
only females, and 16 trials used both sexes. The included
studies that accounted for other potential confounders such
as smoking. 16 of 34 trials in 17 studies were RCTs with
no exercise intervention control group. Table 2 shows the
characteristics of interventions within the included studies.
71% of trials (𝑛 = 24 trials) incorporated aerobic exercise;
18% (𝑛 = 6 trials) and 11% (𝑛 = 4 trials) of trials incorporated
resistance exercise and combined with aerobic and resistance
exercise, respectively. Table 3 shows FMD protocol and
outcomes. 23 trials in 17 studies reported fasting time (ranged
from 0.5 hours to overnight fasting). Brachial artery FMD
was measured in all of the included studies. 71% studies
reportedmean and SD of FMD percentage at preintervention
and postintervention, and the rest of the studies reported
amount of change or 95% confidence interval (CI).Themean
and SD of FMD was 7.15% ± 3.05 (range 2.7 to 11.28%)
before intervention and 8.67% ± 2.62 (range 4 to 12.9%) after
intervention, and rate of change for FMD was 1.17% ± 1.63
(range −1.3 to 5%) in the treatment group. In the control
group, the mean and SD of FMD was 5.69% ± 2.12 (range
2.5 to 9.9%) before intervention and 6.65% ± 2.46 (range 3.8
to 10.1%) after intervention, and rate of change for FMD was
0.61% ± 2.16 (range −0.7 to 4.9%).
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Table 4: Methodological scores by Physiotherapy Evidence Database (PEDro) scale.
Studies PEDro criterion Total score
1 2 3 4 5 6 7 8 9 10 11
Ades et al. (2011) [23] 1 1 1 1 1 0 0 1 1 1 1 9
Baynard et al. (2009) [24] 1 0 0 1 0 0 0 1 1 1 1 6
Bhutani et al. (2013) [25] 1 1 1 1 0 0 0 0 1 1 1 7
Blumenthal et al. (2010) [26] 1 1 1 1 0 0 0 1 1 1 1 8
Choo et al. (2014) [27] 1 1 1 1 1 0 1 0 1 1 1 9
Cotie et al. (2014) [28] 0 0 0 1 0 0 0 1 1 1 1 5
Davison et al. (2008) [29] 1 1 1 1 1 0 1 0 1 1 1 9
Fayh et al. (2013) [30] 1 1 1 1 0 0 0 0 1 1 1 7
Franklin et al. (2015) [31] 1 1 1 1 0 0 0 1 1 1 1 8
Hamdy et al. (2003) [32] 1 0 0 1 0 0 0 0 1 1 1 5
Kwon et al. (2011) [33] 1 1 1 1 0 0 0 1 1 1 1 8
Olson et al. (2006) [34] 1 1 1 1 0 0 1 1 1 1 1 9
Pugh et al. (2014) [35] 1 1 1 1 0 0 0 0 1 1 1 7
Robinson et al. (2016) [36] 1 0 0 1 0 0 0 0 1 1 1 5
Swift et al. (2012) [37] 1 1 1 1 0 0 1 0 1 1 1 8
Vinet et al. (2011) [38] 1 0 0 1 0 0 0 1 1 0 1 5
Wycherley et al. (2008) [39] 1 1 1 1 0 0 0 1 1 1 1 8
Total 16 12 12 17 3 0 4 9 17 16 17
Note. Each number of PEDro criterion is represented as follows: 1: inclusion and source; 2: random allocation; 3: concealed allocation; 4: baseline comparability;
5: blinded subjects; 6: blinded therapists; 7: blinded assessors; 8: outcomes for >85%; 9: intention-to-treat analysis; 10: between-group comparisons; 11: mean
and variability data.
3.4. Quality of Included Studies. Quality score by the PEDro
scale was 7.2±1.5 (ranged from 5 to 9), the median score of 8
of amaximumpossible of 10 (Table 4).This score is equivalent
tomoderate to high quality [42]. All of the studies satisfied the
following criteria: baseline comparability, intention-to-treat
analysis, and mean and variability data. No study reported
having blinded therapists.
3.5. Overall Effect Size. The overall mean ES was 0.522 (95%
CI = 0.257, 0.786) and statistically significant. This quanti-
tative synthesis yielded a medium and positive ES using a
random effect model. This indicates that exercise training is
effective in improving FMD in overweight and obese adults.
Therewas observed to be heterogeneous (𝑄𝑏 = 239,𝑝 ≤ 0.001,
𝐼2 = 86.19), suggesting that moderator analyses are needed to
better understand the exercise intervention effect on FMD.
Figure 2 provides Forest plot with ESs of the analysis results.
3.6. Moderator Analysis. The moderator analyses were per-
formed to examine the effect of body weight change, diet
intervention, exercise modality, comorbidity, and baseline
BMI. The results demonstrated that only comorbidity status
explained the heterogeneity of ESs (𝑄𝑏 = 6.39, df = 1, and
𝑝 = 0.011). Table 5 shows the results of moderator analyses,
which includes ESs, CIs, and Cochran’s 𝑄 statistics for each
moderator variables. A large ESwas found in the combination
exercise, low intensity exercise, and comorbidity subgroups
(ES = 0.82∼1.24). A moderate to large ES was found in body
weight loss, with and without diet intervention, more than
12-week exercise duration, aerobic exercise, and between 30
and 34.9 baseline BMI (ES = 0.51∼0.71).
4. Discussion
In this meta-analysis, we found 34 trials from 17 studies
including 1,045 overweight and obese adults. The meta-
analysis result showed that exercise training significantly
improves vascular function as measured by FMD of the
brachial artery.The studies were randomized controlled trials
of control and noncontrol groups of Asian andWestern adult
populations. Endothelial dysfunction is inherent in over-
weight and obese adults, and exercise training is universally
accepted to ameliorate the obesity-associated endothelial
dysfunction in healthy adults [16, 44]; however, more exami-
nation of the specific effects of exercise training onEF in over-
weight and obese population is still needed. Therefore, we
combined data from each of the clinical trials to understand
the relationship between exercise training and EF in over-
weight and obese adults.
Our results demonstrated that exercise has a moderate
benefit on the improvement of FMDon overweight and obese
adult populations in exercise intervention studies. When we
probed moderators to examine the possible associations with
ESs, we found that only comorbidity status influences the
effectiveness of exercise intervention on EF. To our knowl-
edge, we are the first to report this result. The finding could
explain why exercise may not reverse the reduction of FMD
attributable solely to obesity in isolation, whereas exercise
8 International Journal of Vascular Medicine
Study name
Statistics for each study




Ades et al. (2011) a 1.014 0.511 1.517
Ades et al. (2011) b 0.328 −0.191 0.848
Baynard et al. (2009) a −0.364 −1.004 0.276
Baynard et al. (2009) b 0.273 −0.358 0.904
Baynard et al. (2009) c −0.197 −0.794 0.400
Baynard et al. (2009) d −1.625 −2.525 −0.725
Bhutani et al. (2013) a −1.652 −2.351 −0.952
Bhutani et al. (2013) b 0.489 −0.152 1.131
Blumenthal et al. (2010) 0.200 −0.203 0.603
Choo et al. (2014) a 0.074 −0.240 0.388
Choo et al. (2014) b −0.053 −0.367 0.261
Choo et al. (2014) c −0.160 −0.476 0.156
Choo et al. (2014) d 0.217 −0.172 0.606
Choo et al. (2014) e 0.139 −0.247 0.526
Choo et al. (2014) f 0.270 −0.121 0.662
Choo et al. (2014) g 0.023 −0.354 0.400
Choo et al. (2014) h 0.353 −0.036 0.742
Choo et al. (2014) i 0.074 −0.304 0.451
Cotie et al. (2014) 5.209 3.536 6.881
Davison et al. (2008) a 1.609 0.686 2.532
Davison et al. (2008) b −0.110 −0.895 0.675
Fayh et al. (2013) 0.545 −0.130 1.220
Franklin et al. (2015) 0.274 −0.660 1.208
Hamdy et al. (2003) 4.490 3.158 5.822
Kwon et al. (2011) a 1.521 0.678 2.364
Kwon et al. (2011) b 0.617 −0.159 1.394
Olson et al. (2006) 1.155 0.382 1.928
Pugh et al. (2014) 3.470 2.359 4.581
Robinson et al. (2016) −0.216 −1.119 0.687
Swi et al. (2012) a 1.000 0.278 1.722
Swi et al. (2012) b 1.500 0.472 2.528
Swi et al. (2012) c 1.200 0.172 2.228
Vinet et al. (2011) 4.583 2.481 6.684




−8.00 −4.00 0.00 4.00 8.00
Figure 2: Forest plot illustrating effect of exercise intervention on FMD.
may reverse the portion attributable to a comorbidity. While
the explanation contrasts two previousmeta-analyses [16, 45]
showing that exercise is an effectivemethod to improve FMD,
they use pooled data from both obese and nonobese groups.
If obesity acts on FMD in an exercise-independent way, it
is possible that our finding of an FMD improvement results
from the influence of exercise intervention on the portion of
FMD decrement attributable to the comorbidity, rather than
on the portion of FMD decrement attributable to obesity.
We were unable to extrapolate the underlying mechanism
of this finding, because it is beyond the scope of our study.
Further research is required to examine different populations
according to study characteristics (age, type of disease,
stage of disease, exercise intensity, exercise type, treatment
modality, etc.).
The examination of mean ES and 95 CI of each subgroup
showed that ES is above medium in the subgroups with
weight loss whereas there is no significant benefit of exercise
intervention in the weight gain group. Although the mech-
anism of the effects of weight loss on FMD in overweight
and obese adults requiresmore elucidation, numerous studies
confirm the positive effects ofweight loss by exercise on FMD.
The beneficial effect of weight reduction by lifestyle changes,
such as exercise to improve vascular function in obese adults,
is strongly supported in [46], and a meta-analysis of the
relationship between weight change and EF has reported a
positive correlation between weight loss and an increase in
FMD [45]. Therefore, it is speculated that weight reduction
may be a major factor enhancing FMD in obese individuals
and may depend on the method of weight reduction.
A study of the effect of surgically induced weight loss on
FMD in hypertensive obese patients showed that bariatric
surgery-induced weight loss improves blood pressure (BP),
high-sensitivity C-reactive protein (hs-CRP), leptin, home-
ostasis model assessment (HOMA-IR), and abdominal fat,
whereas FMD does not improve [47]. A study examining
the effects of dietary weight loss on vascular function in
obese men demonstrated that diet-induced weight reduction
decreases aortic stiffness, total and low-density lipoprotein
cholesterol, triglycerides, insulin resistance, and BP without
alteration of FMD [48]. Similarly, our results demonstrate
the significant benefit of exercise on FMD in overweight and
obese adults regardless of diet control. Taken together, the
above results indicating that exercise-mediated weight loss
may improve FMD, but not diet control or surgery, suggest
that exercise is a key regulator of FMD in overweight and
obese adults. The notion that exercise-induced shear stress
improves FMD in overweight and obese adults through an
increase in the activity and expression of endothelial nitric
oxide synthase (eNOS) that augments NO bioavailability also
supports the suggestion [49–51].
We also found amoderate to large beneficial effect of exer-
cise in the longer-period intervention subgroup than with 12
weeks of exercise program, and no significant benefit in the
International Journal of Vascular Medicine 9
Table 5: Subgroup analysis.
Moderator variable 𝑛 ES 95% CI 𝑄𝑏Lower Upper
Body weight change
Increase 7 0.10 −0.50 0.70
2.5450–2.9 kg loss 19 0.61 0.26 0.97
≥3 kg loss 8 0.70 0.12 1.28
Diet intervention
Yes 20 0.51 0.18 0.85 0.008
No 14 0.54 0.11 0.97
Exercise duration
<12 weeks 8 0.09 −0.50 0.68
2.86812–23 weeks 15 0.61 0.20 1.02
≥24 weeks 11 0.71 0.24 1.18
Exercise type
Resistance 6 0.43 −0.22 1.07
0.601Aerobic 24 0.52 0.18 0.85
Combined 4 0.82 0.01 1.62
Exercise intensity
Low 3 1.24 0.29 2.19
2.401Moderate 30 0.47 0.19 0.75
High 1 0.27 −1.38 1.93
Comorbidity
No 21 0.26 −0.06 0.58 6.392∗
Yes 13 0.95 0.52 1.37
Baseline BMI
25–29.9 12 0.31 −0.11 0.73
1.64730–34.9 19 0.67 0.30 1.04
≥35 3 0.66 −0.28 1.61
Note. ∗𝑝 < 0.05.
groupwith less than 12 weeks of intervention.We suggest that
at least 12 weeks of exercise intervention may improve FMD
in overweight and obese adults. Although previous reviews
hypothesized that a longer durationmay increase efficacy and
maintain the effect on EF from the exercise intervention [16,
44], ourmeta-analysis provides the first quantitative evidence
of the optimal exercise intervention duration to improve EF
in overweight and obese adults.
Asmentioned, exercisemodality and intensity to improve
EF remains controversial. For example, a meta-analysis of
obese and nonobese adults showed that any type of exer-
cise, including resistance, aerobic, and combined training
improves EF [16]; however, another meta-analysis demon-
strated that resistance exercise associates with increased
arterial stiffness [18]. Our results confirmed no effect in the
resistance exercise, medium to large effect in the aerobic exer-
cise, and large effect in the combined exercise. We interpret
our findingswith caution, becausemore than 70%of included
studies utilized aerobic exercises as an intervention modality.
Furthermore, a recent study showed that high intensity exer-
cise improves FMD more than moderate intensity, because
higher intensity exercise causes greater shear stress resulting
in more NO activation [17], even though other studies
reported that high intensity exercise significantly reduces
FMD [19, 20]. Our meta-analysis results showed that high
intensity exercise has no effect, whereas low and moderate
intensity exercise have large and medium ESs, respectively.
Again, we interpret the results with caution, because a limited
number of studies reported results for high (𝑛 = 1) and low
(𝑛 = 3).
Moderator analysis also demonstrated that adults with
a BMI 30–34.9 (level 1 obesity) have large and medium to
large beneficial effect from exercise, respectively, whereas
adults without a comorbidity and BMI < 30 or ≥35 have no
significant benefit from exercise. Previously, Joris et al. [45]
reported that the effects on FMD linearly relate to amount
of weight loss in groups with obesity-related morbidities
compared with healthy adults. Since this study pooled obese
and nonobese adults and it did not break down groups by
method of weight loss, a direct comparison with our study is
not possible, because our data include only obese adults [45].
The effect of exercise on FMD may also depend on
baseline BMI. Our result showed that only adults with level
1 obesity have a benefit from exercise training on FMD. A
meta-analysis byAshor et al., however, showed a greater effect
of exercise on FMD in nonobese individuals than in obese
10 International Journal of Vascular Medicine
individuals [16]. Again, a direct comparison is not possible.
Further research should clarify the relationship between
baseline obesity and exercise effect on FMD.
This study must be interpreted in the context of multiple
limitations. First, the range in FMD levels in the studies
is relatively small, and there is substantially less data for
those with BMI > 35. Second, there were methodological
limitations. FMD is well known for being operator and
protocol dependent, and there was considerable variation in
FMDdata collectionmethodology [52, 53].Therefore, further
well-controlled studies are needed to draw accurate conclu-
sions.
In summary, our meta-analysis indicates that exercise
training is able to improve EF in overweight and obese adults,
and that the effect of exercise may depend on the different
characteristics of exercise intervention and on participants’
demographics.
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